Skip to main content
Circa Group AS logo

Circa Group AS — Investor Relations & Filings

Ticker · CIRCA ISIN · NO0010917594 LEI · 549300TYMT7PQV920R92 OL Manufacturing
Open in API
Filings indexed 376 across all filing types
Latest filing 2022-07-04 Director's Dealing
Country NO Norway
Listing OL CIRCA

About Circa Group AS

https://circa-group.com/

Circa Group AS is a renewable chemicals company that develops and commercializes bio-based products. It utilizes a proprietary thermochemical process, Furacell™, to convert non-food, waste cellulosic biomass into advanced biochemicals. The company's portfolio is centered on the platform chemical levoglucosenone (LGO) and its derivatives, most notably the bio-based solvent Cyrene™. Cyrene™ is designed as a safer, more sustainable alternative to traditional, fossil-derived polar aprotic solvents like NMP. Circa aims to produce these biochemicals at an industrial scale, serving various markets, including pharmaceuticals, agrochemicals, and specialty polymers, that are transitioning to greener chemistry. The company is scaling up its manufacturing capabilities through its ReSolute plant project.

Recent filings

Filing Released Lang Actions
Primary insider notice
Director's Dealing Classification · 99% confidence The document is explicitly titled "Notification of transactions by Primary Insiders and Close Associates" and details the acquisition of shares by an individual named Philipp Morgenthaler, who is identified as a Primary Insider and Head of Manufacturing. This content directly corresponds to the reporting of personal share transactions by company directors and executives, which matches the definition for Director's Dealing (DIRS).
2022-07-04 English
Primary insider notice
Director's Dealing Classification · 99% confidence The document is titled 'Primary insider notice' and details a share purchase by Philipp Morgenthaler, identified as 'Head of Manufacturing' and a 'primary insider' of Circa Group AS. This transaction involves an executive buying shares of the company. This directly corresponds to the definition of Director's Dealing (insider trades). The document length is short (1486 chars) and it mentions referring to 'attached notifications of trading for further details,' but the core content is the insider transaction itself, making 'Director's Dealing' (DIRS) the most specific and accurate classification, rather than a general 'Report Publication Announcement' (RPA) or 'Regulatory Filing' (RNS).
2022-07-04 English
Primary insider notice
Director's Dealing Classification · 98% confidence The document is titled "Notification of transactions by Primary Insiders and Close Associates" and details a transaction involving warrants exercised by an associate of a Primary Insider (Tony Duncan). This type of filing specifically reports personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS). The document is not a comprehensive annual report (10-K), an earnings release (ER), or a general regulatory announcement (RNS), but a specific insider transaction report.
2022-07-01 English
Primary insider notice
Share Issue/Capital Change Classification · 99% confidence The document is titled "Primary insider notice" and details a transaction (exercise of warrants leading to share issuance) by a close associate of the CEO, Tony Duncan. This type of filing reports personal share transactions by company directors and executives (insiders). This directly corresponds to the definition of Director's Dealing (DIRS). The document is short and reports a specific transaction, not a general announcement of a report.
2022-07-01 English
Financial calendar
Report Publication Announcement Classification · 99% confidence The document text is extremely short (302 characters) and explicitly lists a 'Financial calendar' for the company, detailing dates for future report releases such as 'Half-yearly Report' and 'Quarterly Report - Q3'. It does not contain the content of these reports. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement regarding the timing or publication of reports should be classified as a Report Publication Announcement (RPA).
2022-06-23 English
CIRCA’S LEVOGLUCOSENONE DERIVATIVE USED IN AWARD WINNING MANUFACTURING METHOD FOR INVESTIGATIONAL CANCER DRUG
Regulatory Filings Classification · 85% confidence The document is structured as a 'PRESS RELEASE' announcing a specific achievement: Circa's derivative was used in an award-winning manufacturing method for an investigational cancer drug. It details an external award (Peter J. Dunn Award), quotes management (CTO, CFO), and provides company background. This type of announcement, focusing on a specific operational or scientific milestone, does not fit the definitions for formal financial reports (10-K, IR, ER, MRQ) or corporate governance filings (DEF 14A, CGR). It is a general corporate update. Since there is no specific category for 'Press Release' or 'Operational Update', and it is not a report announcement (RPA) or a standard regulatory filing (RNS), the most appropriate fallback category is 'Regulatory Filings' (RNS), as press releases often serve as the primary means of broad, non-mandated regulatory disclosure when a specific category is unavailable. However, given the content is a general business/operational announcement rather than a mandatory filing, and it is not a transcript, dividend notice, or management change, RNS is the best fit among the provided options for a general announcement.
2022-06-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.